首页> 美国卫生研究院文献>Experimental and Therapeutic Medicine >Prediction of clinical outcome using p16INK4a immunocytochemical expression in low-grade squamous intraepithelial lesions and high-risk HPV-positive atypical squamous cells of undetermined significance in patients with and without colposcopic evident cervical disease
【2h】

Prediction of clinical outcome using p16INK4a immunocytochemical expression in low-grade squamous intraepithelial lesions and high-risk HPV-positive atypical squamous cells of undetermined significance in patients with and without colposcopic evident cervical disease

机译:使用p16INK4a免疫细胞化学表达预测低水平鳞状上皮内病变和高危HPV阳性非典型鳞状细胞癌临床结果的不确定性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

p16INK4a as a diagnostic marker of a cervical intraepithelial neoplasia of grade 2+ (CIN2+) in atypical squamous cells of undetermined significance (ASC-US) and low-grade squamous intraepithelial lesion (LSIL) cytological samples has been analyzed, but has not yet been included in clinical routine practice. One hundred and ninety-one patients with an abnormal Pap test (84 ASC-US and 107 LSILs) who underwent colposcopy were selected for this study. At enrollment, 96 patients (Group 1) had a positive colposcopy and therefore underwent a cervical biopsy, while 95 (Group 2) had a negative colposcopy and were followed up for up to 1 year. Both groups were tested for p16INK4a using immunocytochemical methods, and the p16INK4a results were correlated with histology or follow-up outcome. In Group 1 ASC-US cases, 82% of lesions less than CIN2 were p16INK4a-negative and all CIN2 cases were p16INK4a-positive (p=0.00044). In Group 1 LSIL cases, 71% of lesions less than CIN2 were p16INK4a-negative and 87% of CIN2/3 were p16INK4a-positive (p=0.00033). Seventy-seven percent of Group 2 ASC-US patients with a negative 1-year follow-up (NF-U) were p16INK4a-negative at enrollment, while all patients with positive follow-up (PF-U) were p16INK4a-positive (p=0.00113). In Group 2 LSIL cases, 83% of patients with NF-U were p16INK4a-negative, while 65% of patients with PF-U were p16INK4a-positive at enrollment (p=0.0014). In fact, 39% of the positive p16INK4a LSIL patients had CIN2+ histological lesions. The positive predictive value of p16INK4a for CIN2+ was 50% in ASC-US and 52% in LSIL cases; the negative predictive value was 100 and 94%, respectively. In conclusion, in our patients, a negative p16INK4a appears to be a marker of the absence of CIN3, while a positive p16INK4a can be correlated with the presence of histological CIN2+ found at enrollment or during the subsequent follow-up. Thus, its clinical predictive value is independent from the colposcopic aspect at enrollment.
机译:p16INK4a作为具有重要意义的非典型鳞状上皮鳞癌(ASC-US)和低度鳞状上皮内病变(LSIL)细胞学样本中2+级宫颈上皮内瘤样病变(CIN2 +)的诊断标志物,但尚未进行分析包括在临床常规操作中。本研究选择了119例接受阴道镜检查且巴氏试验异常(84例ASC-US和107例LSIL)的患者。入组时,96例(第1组)的阴道镜检查为阳性,因此接受了宫颈活检,而95例(第2组)的阴道镜检查为阴性,随访了1年。两组均使用免疫细胞化学方法检测了p16INK4a,p16INK4a结果与组织学或随访结果相关。在第1组ASC-US病例中,小于CIN2的病变中有82%为p16INK4a阴性,所有CIN2病例均为p16INK4a阳性(p = 0.00044)。在第1组LSIL病例中,小于CIN2的病变中有71%为p16INK4a阴性,而CIN2 / 3的87%为p16INK4a阳性(p = 0.00033)。 1年随访阴性(NF-U)的第2组ASC-US患者中有77%在入组时p16INK4a阴性,而所有随访阳性(PF-U)的患者均为p16INK4a阳性( p = 0.00113)。在第2组LSIL病例中,入组时83%的NF-U患者为p16INK4a阴性,而65%的PF-U患者为p16INK4a阳性(p = 0.0014)。实际上,有39%的p16INK4a LSIL阳性患者患有CIN2 +组织学病变。 p16INK4a对CIN2 +的阳性预测值在ASC-US中为50%,在LSIL患者中为52%。阴性预测值分别为100%和94%。总之,在我们的患者中,阴性的p16INK4a似乎是不存在CIN3的标志物,而阳性的p16INK4a可能与入组时或后续随访中发现的组织学CIN2 +有关。因此,其临床预测价值与入组时的阴道镜检查无关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号